<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoffmann MJ</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>260</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7916885</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(2)</volume><pubmed_abstract>Since genes encoding epigenetic regulators are often mutated or deregulated in urothelial carcinoma (UC), they represent promising therapeutic targets. Specifically, inhibition of Class-I histone deacetylase (HDAC) isoenzymes induces cell death in UC cell lines (UCC) and, in contrast to other cancer types, cell cycle arrest in G2/M. Here, we investigated whether mutations in cell cycle genes contribute to G2/M rather than G1 arrest, identified the precise point of arrest and clarified the function of individual HDAC Class-I isoenzymes. Database analyses of UC tissues and cell lines revealed mutations in G1/S, but not G2/M checkpoint regulators. Using class I-specific HDAC inhibitors (HDACi) with different isoenzyme specificity (Romidepsin, Entinostat, RGFP966), cell cycle arrest was shown </pubmed_abstract><journal>Genes</journal><pubmed_title>Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.</pubmed_title><pmcid>PMC7916885</pmcid><funding_grant_id>HO 6448/ NI 1398</funding_grant_id><pubmed_authors>Hommel K</pubmed_authors><pubmed_authors>Meneceur S</pubmed_authors><pubmed_authors>Schulz WA</pubmed_authors><pubmed_authors>Hoffmann MJ</pubmed_authors><pubmed_authors>Niegisch G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.</name><description>Since genes encoding epigenetic regulators are often mutated or deregulated in urothelial carcinoma (UC), they represent promising therapeutic targets. Specifically, inhibition of Class-I histone deacetylase (HDAC) isoenzymes induces cell death in UC cell lines (UCC) and, in contrast to other cancer types, cell cycle arrest in G2/M. Here, we investigated whether mutations in cell cycle genes contribute to G2/M rather than G1 arrest, identified the precise point of arrest and clarified the function of individual HDAC Class-I isoenzymes. Database analyses of UC tissues and cell lines revealed mutations in G1/S, but not G2/M checkpoint regulators. Using class I-specific HDAC inhibitors (HDACi) with different isoenzyme specificity (Romidepsin, Entinostat, RGFP966), cell cycle arrest was shown </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-19T05:10:35.187Z</modification><creation>2021-03-03T08:14:22Z</creation></dates><accession>S-EPMC7916885</accession><cross_references><pubmed>33670166</pubmed><doi>10.3390/genes12020260</doi></cross_references></HashMap>